FDA Drug Safety Podcast: FDA warns that prescribing of Nizoral (ketoconazole) oral tablets for unapproved uses including skin and nail infections continues; linked to patient death
(Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - February 9, 2019 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
FDA Drug Safety Podcast: FDA warns that prescribing of Nizoral (ketoconazole) oral tablets for unapproved uses including skin and nail infections continues; linked to patient death
On May 19, 2016, FDA announced it is warning health care professionals to avoid prescribing the antifungal medicine ketoconazole oral tablets to treat skin and nail fungal infections. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - June 3, 2016 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
Ketoconazole: FDA Planning to Pull It Off the Shelf?
The FDA has strengthened warnings and withdrawn an indication for ketoconazole. Paul G. Auwaerter, MD, offers his comments on both the FDA and EMA actions on this drug. (Source: Medscape Emergency Medicine Podcast)
Source: Medscape Emergency Medicine Podcast - August 9, 2013 Category: Emergency Medicine Authors: Medscape Source Type: podcasts
